Document is current

Any future updates will be listed below

Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom

Crossref DOI link: https://doi.org/10.1007/s13300-017-0237-8

Published Online: 2017-02-24

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark